CD19 and Burkitt lymphoma: We report a patient with BL who, post-CD19 CAR-T cell therapy, experienced both CRS and IEC-HS, resulting in pancytopenia and BM findings most consistent with aplasia requiring emergent transplant for hematopoietic recovery.